Xiidra vs. Xiidra + Dextenza Treatment for Dry Eye Disease

NCT04413253 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

5

Enrollment

NETWORK

Sponsor class

Stopped Unable to recruit

Conditions

Dry Eye Syndromes

Interventions

DRUG: Lifitegrast 5% Ophthalmic Solution
DRUG: Dexamethasone Intracanalicular Insert, 0.4mg with Lifitegrast 5% Ophthalmic Solution

Sponsor

Eye Surgeons of Indiana

Collaborators

[object Object]